Abstract
Sympathomimetics constitute a large group of drugs with a spectrum of uses that range from over-the-counter cough and cold preparations to critical care medications. Their clinical effects are similar and theoretically should be predictable based on an understanding of the specific pharmacology of the drugs. However, because of the complexity of the autonomic nervous system and its responses to physiologic changes within the body, the actual clinical effects of these drugs vary and may be unpredictable.
The original version of this chapter was revised: The second affiliation of R.J. Hoffman was erroneously included.
An erratum to this chapter can be found at DOI 10.1007/978-3-319-17900-1_186.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Toaimah FH, Al-Ansari K. Life-threatening cardiac arrhythmia after a single dose of nebulized epinephrine in pediatric emergency department. J Trop Pediatr. 2011;57:497–9.
Kanwar M, Irvin CB, Frank JJ, Weber K, Rosman H. Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution. Ann Emerg Med. 2010;55:341–4.
Hoyle JD, Davis AT, Putman KK, Trytko JA, Fales WD. Medication dosing errors in pediatric patients treated by emergency medical services. Prehosp Emerg Care. 2012;16(1):59–66.
Arfi AM, Kouatli A, Al-Ata J, Arif H, Syed S. Acute myocardial ischemia following accidental intravenous administration of epinephrine in high concentration. Indian Heart J. 2005;57:261–4.
Muck AE, Berbarta VS, Borys DJ, Morgan DL. Six years of epinephrine digital injections: absence of significant local or systemic effects. Ann Emerg Med. 2010;56:270–4.
Hinterberger JW, Kintzi HE. Phentolamine reversal of epinephrine-induced digital vasospasm: how to save an ischemic finger. Arch Fam Med. 1994;3:193–5.
Zell-Kanter M, Quigley MA, Leikin JB. Reduction in ephedra poisonings after FDA ban. N Engl J Med. 2015;372:2172–4.
Chan KH, Hsu MC, Chen FA, Hsu KF. Elimination of ephedrines in urine following administration of a Sho-seiryu-to preparation. J Anal Toxicol. 2009;33:162–6.
Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011. http://accessmedicine.mhmedical.com.ils.sidra.org/content.aspx?bookid=1613&Sectionid=102158209. Accessed 28 Apr 2016.
McGraw DW, Liggett SB. Molecular mechanisms of β2-adrenergic receptor function and regulation. Proc Am Thorac Soc. 2005;2:292–6.
Bridgeman MB, Friia NJ, Taft C, Shah M. Mirabegron: β3-adrenergic receptor agonist for the treatment of overactive bladder. Ann Pharmacother. 2013;47:1029–38.
Klontz KC, Timbo BB, Street D. Consumption of dietary supplements containing Citrus aurantium (bitter orange) – 2004 California Behavioral Risk Factor Surveillance Survey (BRFSS). Ann Pharmacother. 2006;40:1747–51.
Budhwani N, Bonaparte KL, Cuyjet AB, Saric M. Severe reversible left ventricular systolic and diastolic dysfunction due to accidental iatrogenic epinephrine overdose. Rev Cardiovasc Med. 2004;5:130–3.
Woodard ML, Brent LD. Acute renal failure, anterior myocardial infarction, and atrial fibrillation complicating epinephrine abuse. Pharmacotherapy. 1998;18:656–8.
Davis CO, Wax PM. Prehospital epinephrine in a child resulting in ventricular dysrhythmias and myocardial ischemia. Pediatr Emerg Care. 1999;15:116–8.
Butte MJ, Nguyen BX, Hutchinson TJ, et al. Pediatric myocardial infarction after racemic epinephrine administration. Pediatrics. 1999;104:e9.
Tajima K, Sato S, Miyabe M. A case of pulmonary edema and bulbar paralysis after local epinephrine infiltration. J Clin Anesth. 1997;9:236–8.
Horowitz BZ, Jadallah S, Derlet RW. Fatal intracranial bleeding associated with prehospital use of epinephrine. Ann Emerg Med. 1996;28:725–7.
Andrzejowski J, Sleigh JW, Johnson IAT, Sikiotis L. The effect of intravenous epinephrine on the bispectral index and sedation. Anaesthesia. 2000;55:761–3.
Hoffman RJ. Methylanthines and β2 agonists. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank’s toxicologic emergencies. 10th ed. New York: McGraw Hill; 2015.
McGraw DW, Liggett SB. Molecular mechanisms of β2-adrenergic receptor function and regulation. Proc Am Thorac Soc. 2005;2:292–6.
Hoffman RJ, Hoffman RS, Freyberg CL, Poppenga RH, Nelson LS. Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. J Toxicol Clin Toxicol. 2001;39:339–44.
Hoffman RS, Kirrane BM, Marcus SM, Clenbuterol Study Investigators. A descriptive study of an outbreak of clenbuterol-containing heroin. Ann Emerg Med. 2008;52:548–53.
Chan TY. Health hazards due to clenbuterol residues in food. J Toxicol Clin Toxicol. 1999;37:517–9.
Craig VL, Bigos D, Brilli RJ. Efficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus. Pediatr Emerg Care. 1996;12:1–5.
Craig TJ, Smits W, Soontornniyomiu V. Elevation of creatinine kinase from skeletal muscle with inhaled albuterol. Ann Allergy Asthma Immunol. 1996;77:488–90.
King WD, Holloway M, Palmisano PA. Albuterol overdose: a case report and differential diagnosis. Pediatr Emerg Care. 1992;8:268.
Travers AH, Milan SJ, Jones AP, Camargo Jr CA, Rowe BH. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev. 2012;12:CD010179.
Kalyanaraman M, Bhalala U, Leoncio M. Serial cardiac troponin concentrations as marker of cardiac toxicity in children with status asthmaticus treated with intravenous terbutaline. Pediatr Emerg Care. 2011;27:933–6.
Udezue E, D’Souza L, Manajan M. Hypokalemia after normal doses of nebulized albuterol (salbutamol). Am J Emerg Med. 1995;13:168–71.
Wasserman D, Amitai Y. Hypoglycemia following albuterol overdose in a child. Am J Emerg Med. 1992;10:556.
King WD, Holloway M, Palmisano PA. Albuterol overdose: a case report and differential diagnosis. Pediatr Emerg Care. 1992;8:268–71.
Bodenhamer J, Bergstrom R, Brown D, et al. Frequently nebulized beta-agonists for asthma: effects on serum electrolytes. Ann Emerg Med. 1992;21:1337–42.
Wiley 2nd JF, Spiller HA, Krenzelok EP, Borys DJ. Unintentional albuterol ingestion in children. Pediatr Emerg Care. 1994;10:193–6.
Huckins DS, Lemons MF. Myocardial ischemia associated with clenbuterol abuse: report of two cases. J Emerg Med. 2013;44:444–9.
Kierzkowska B, Stan’czyk J, Kasprazak JD. Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ J. 2005;69:1144–6.
Centers for Disease Control and Prevention. Atypical reactions associated with heroin use-five states. MMWR Morb Mortal Wkly Rep. 2005;54:793–6.
Yasuda R, Makino Y, Matsuda Y, Kawamichi Y, Matsui H. Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms. J Obstet Gynaecol Res. 2012;38:574–7.
Shoji T, Takatori E, Oyama R, et al. Tako-Tsubo cardiomyopathy caused immediately following cesarean section delivery of triplets: a case report. Gynecol Obstet Invest. 2012;74:84–8.
Fornet I, Calvo M, Gimeno M, Canser E, Alonso E, Gilsanz F. Acute myocardial infarction during tocolytic treatment with ritodrine. Rev Esp Anestesiol Reanim. 2006;53:312–4.
Kimura M, Kato T, Nohara R. Pulmonary edema complicating ritodrine infusion in a patient with premature labor. Intern Med. 2013;52(1):155.
Nakajima Y, Masaoka N, Tsuduki Y, Honda N, Sakai M. Rhabdomyolysis caused by tocolytic therapy with oral ritodrine hydrochloride in a pregnant woman with placenta previa. J Obstet Gynaecol Res. 2011;37:629–32.
Gezginç K, Gül M, Karatayli R, Cander B, Kanat F. Noncardiogenic pulmonary edema due to ritodrine usage in preterm labor. Taiwan J Obstet Gynecol. 2008;47:101–2.
AusPAR Betmiga mirabegron Astellas Pharma Australia Pty Ltd PM-2012-01928-3-3. June 2014.
Summary Review: Application 202611Orig1s000. US FDA Center for Drug Evaluation and Research; 2012. p. 7.
Kauffmann S, Commun F, Schoeffler P, Souteyrand G, Chiambaretta F. Cardiovascular adverse effects due to phenylephrine eye drops in ophthalmic surgery. Ann Fr Anesth Reanim. 2013;32:112–4.
Tark BE, Messe SR, Balucani C, Levine SR. Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature. J Stroke Cerebrovasc Dis. 2014;23:2296–300.
Fraunfelder FT, Meyer SM. Possible adverse effects from topical ocular 10% phenylephrine. Am J Ophthalmol. 1985;85:447–53.
Thomas JE, Munir JA, McIntyre PZ, Ferguson MA. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature. Tex Heart Inst J. 2009;36:586–90.
Nykamp DL, Fackih MN, Compton AL. Possible associated of acute lateral-wall myocardial infarction and bitter orange supplement. Ann Pharmacother. 2004;38:812–6.
Sultan S, Spector J, Mitchell RM. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. Mayo Clin Proc. 2006;81:1630–1.
Burke J, Seda G, Allen D, Knee TS. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement. Mil Med. 2007;172:656–8.
Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med. 1985;14:1112–3.
Dattilo PB, Hailpern SM, Fearon K, et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51:117–25.
Maguire WM, Reisdorff EJ, Smith D, Wiegenstein JG. Epinephrine-induced vasospasm reversed by phentolamine digital block. Am J Emerg Med. 1990;8:46–7.
Stier P, Bogner M, Webster K, et al. Subcutaneous terbutaline to reverse peripheral ischemia. J Toxicol Clin Toxicol. 1997;35:543.
Stier PA, Bogner MP, Webster K, et al. Use of subcutaneous terbutaline to reverse peripheral ischaemia. Am J Emerg Med. 1999;1:91–4.
Peyko V, Cohen V, Jellinek-Cohen SP, Pearl-Davis M. Evaluation and treatment of accidental autoinjection of epinephrine. Am J Health Syst Pharm. 2013;70(9):778–81.
Ramoska EA, Henretig F, Joffe M, Spiller HA. Propranolol treatment of albuterol poisoning in two asthmatic patients. Ann Emerg Med. 1993;22:1474–6.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Grading System for Levels of Evidence Supporting Recommendations in Critical Care Toxicology, 2nd Edition
-
I
Evidence obtained from at least one properly randomized controlled trial.
-
II-1
Evidence obtained from well-designed controlled trials without randomization.
-
II-2
Evidence obtained from well-designed cohort or case–control analytic studies, preferably from more than one center or research group.
-
II-3
Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of the introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence.
-
III
Opinions of respected authorities, based on clinical experience, descriptive studies and case reports, or reports of expert committees.
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Hoffman, R.J., Nelson, L.S. (2017). Sympathomimetic Agents. In: Brent, J., et al. Critical Care Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-319-17900-1_107
Download citation
DOI: https://doi.org/10.1007/978-3-319-17900-1_107
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17899-8
Online ISBN: 978-3-319-17900-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences